Market Update


 

TIDMYRK 
 
RNS Number : 1983P 
York Pharma plc 
20 March 2009 
 

 
 
20 March 2009 
 
 
York Pharma plc 
(YRK.L) ("York" or the "Company") 
 
 
Market Update 
 
 
In January 2009, York announced that its newly appointed management team were 
investigating options to address the Company's short term funding needs and that 
the Company's results for the financial year ended 30 September 2008 ('the 
Results') would be released today. 
 
On 2 March 2009, the Board confirmed that the Company had made an approach to a 
potential offeror which may or may not lead to an offer being made for the 
Company. The Board remains in discussions with this and another potential 
offeror. These discussions also include provision of the necessary short term 
funding facilities to allow the Company to continue trading through the period 
needed to complete any formal offer for the Company under the Takeover Code. 
The Board remains hopeful that a positive outcome to these discussions can be 
achieved. 
 
 
Publication of the Results will now take place after the Company has secured its 
short term funding needs and the Board will provide a further update shortly. 
 
 
For more information please contact: 
 
+-----------------------------------------+------------------------------+ 
| York Pharma plc                         | Tel: +44 (0) 870 066 4453    | 
| Richard Anderson, Chief Executive       |                              | 
| Officer                                 |                              | 
+-----------------------------------------+------------------------------+ 
| Collins Stewart Europe Limited          | Tel: +44 (0) 207 523 8350    | 
| Hugh Field / Adam Cowen                 |                              | 
+-----------------------------------------+------------------------------+ 
| FinnCap                                 | Tel: +44 (0) 207 600 1658    | 
| Geoff Nash                              |                              | 
+-----------------------------------------+------------------------------+ 
| Financial Dynamics                      | Tel: +44 (0) 207 831 3113    | 
| Ben Brewerton / Emma Thompson           |                              | 
+-----------------------------------------+------------------------------+ 
 
 
Collins Stewart Europe Limited ("Collins Stewart") which is regulated in the 
United Kingdom by The Financial Services Authority is acting for the Company in 
relation to the matters described in this announcement and is not advising any 
other person, and accordingly will not be responsible to anyone other than the 
Company for providing the protections afforded to customers of Collins Stewart 
or for providing advice in relation to the matters described in this 
announcement. 
 
About York Pharma plc 
York Pharma plc is a pharmaceutical group, established in 2003, which develops, 
markets and supplies branded dermatological products to pharmaceutical 
wholesalers, hospitals and general practitioners within the field of 
dermatology. 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 OFDPUUAPWUPBUBU

York Pharma (LSE:YRK)
過去株価チャート
から 5 2024 まで 6 2024